good candidates for glp 1 Who is (and is Not) a Candidate GLP-1 Weight Loss? Who's a Good Candidate for
Description
The number of patients included in the studies ranges from 1 (case report) to 440.089, with a median of 355 (IQR 1295) subjects

In 2023, semaglutide (the active ingredient in Wegovy & Ozempic) was added to updated PCOS treatment guidance due to its ability to address insulin resistance

Monitor Your Progress

Archived from the original on August 31, 2025

Contributor Information Dariush Mozaffarian, Email: [email protected]
Their once-a-week administration makes them more convenient and easier to use compared to taking a daily pill or shot of insulin
